04/22/2024 3:10 PM | Dube Michael P (Reporting) Intellia Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/15/2024 3:21 PM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/22/2024 8:26 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/26/2024 6:04 AM | Intellia Therapeutics (Filer)
| Form 424B5 | |
02/23/2024 4:22 PM | Intellia Therapeutics (Filer)
| Form 424B5 | |
02/23/2024 4:17 PM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
01/29/2024 3:00 PM | ARK Investment Management LLC (Filed by) Intellia Therapeutics (Subject)
| Form SC 13G/A | |
01/24/2024 10:21 AM | Intellia Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/10/2024 3:15 PM | Intellia Therapeutics (Issuer) Sepp-Lorenzino Laura (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:35 PM | BlackRock Inc. (Filed by) Intellia Therapeutics (Subject)
| Form SC 13G/A | |
01/05/2024 3:44 PM | Clark Eliana (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:45 PM | BASTA JAMES (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:46 PM | Hicks Derek (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:49 PM | Goddard Glenn (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:50 PM | Intellia Therapeutics (Issuer) Sepp-Lorenzino Laura (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:50 PM | Intellia Therapeutics (Issuer) Lebwohl David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:51 PM | Intellia Therapeutics (Issuer) LEONARD JOHN M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:07 PM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2024 4:28 PM | Goddard Glenn (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 4:30 PM | Intellia Therapeutics (Issuer) LEONARD JOHN M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 4:34 PM | Intellia Therapeutics (Issuer) Lebwohl David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 4:35 PM | Intellia Therapeutics (Issuer) Sepp-Lorenzino Laura (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 7:09 PM | Crowley John F (Reporting) Intellia Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023 6:00 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/24/2023 8:30 AM | Intellia Therapeutics (Filer)
| Form S-3ASR | |
11/09/2023 6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 3:42 PM | Bhanji Muna (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2023 6:11 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/18/2023 6:30 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2023 6:19 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/03/2023 3:13 PM | Intellia Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023 6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/02/2023 4:19 PM | Bhanji Muna (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2023 3:45 PM | Bhanji Muna (Reporting) Intellia Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2023 4:21 PM | Bhanji Muna (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 3:22 PM | Bhanji Muna (Reporting) Intellia Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/06/2023 2:34 PM | Clark Eliana (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2023 4:52 PM | Clark Eliana (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 6:39 PM | Clark Eliana (Reporting) Intellia Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023 3:24 PM | Bhanji Muna (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
The "Smart Money" Is Ready for May 1st Are You? (Ad) Former Wall Street VP: "Buy This Stock Now"
Five of America's Most Successful Investors Bought Shares in The Same Company. One Former Wall St. Trader Explains Why… |
06/16/2023 3:26 PM | Cohen Fred E (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 3:13 PM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/12/2023 6:00 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2023 3:52 PM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/04/2023 6:41 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |